|
Search |
Myrexis (MYRX) says it is reorganizing, including an immediate reduction in the Company's workforce by 57 employees or approximately 41%. The reduction was primarily in the company's internal drug discovery group and related support functions. In addition, it will close its research services business.
It will record one-time severance costs of approximately $3 million, which will be recorded in FYQ3.
Earlier, shares were halted. They were last at $3.82.
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up
its...
The Wall Street Journal reports that home prices showed their best year-to-date gains since 2005, up 5.9% through July, signaling the housing market's steady march toward recovery. Also from the Wall Street Journal, IBM (IBM) will increase its efforts to sell so-called cloud computing services...
CEO Marissa Mayer is bringing in some more new blood to Yahoo!, tapping Ken Goldman as the company's new Chief Financial Officer. Goldman's appointment will take effect on October 22nd.
Goldman served as CFO at his most recent employer, Fortinet, having worked at Siebel Systems, Sybase,...
